Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature.
Del Giudice I, Cappelli LV, Delgado J, Niemann CU, Andersen MA, Rotbain EHC, Aarup K, Walewska R, Visentin A, Deodato M, Frustaci AM, Cavalloni C, Gentile M, Yassin MA, Lad D, Scarfò L, Flogegard M, Mattsson M, Raponi S, Ilari C, Starza ID, Orlandi EM, Tedeschi A, Trentin L, Semenzato G, Guarini A, Ghia P, Montserrat E, Foà R. Del Giudice I, et al. Among authors: delgado j. Br J Haematol. 2023 Apr;201(2):353-356. doi: 10.1111/bjh.18696. Epub 2023 Feb 15. Br J Haematol. 2023. PMID: 36793194 Review. No abstract available.
New treatment options for chronic lymphocytic leukemia.
Delgado J, Baumann T, Santacruz R, Montserrat E. Delgado J, et al. Expert Opin Pharmacother. 2014 Apr;15(6):823-32. doi: 10.1517/14656566.2014.891017. Epub 2014 Feb 22. Expert Opin Pharmacother. 2014. PMID: 24559127 Review.
Recurrent mutations refine prognosis in chronic lymphocytic leukemia.
Baliakas P, Hadzidimitriou A, Sutton LA, Rossi D, Minga E, Villamor N, Larrayoz M, Kminkova J, Agathangelidis A, Davis Z, Tausch E, Stalika E, Kantorova B, Mansouri L, Scarfò L, Cortese D, Navrkalova V, Rose-Zerilli MJ, Smedby KE, Juliusson G, Anagnostopoulos A, Makris AM, Navarro A, Delgado J, Oscier D, Belessi C, Stilgenbauer S, Ghia P, Pospisilova S, Gaidano G, Campo E, Strefford JC, Stamatopoulos K, Rosenquist R; European Research Initiative on CLL (ERIC). Baliakas P, et al. Among authors: delgado j. Leukemia. 2015 Feb;29(2):329-36. doi: 10.1038/leu.2014.196. Epub 2014 Jun 19. Leukemia. 2015. PMID: 24943832
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.
Burger JA, Tedeschi A, Barr PM, Robak T, Owen C, Ghia P, Bairey O, Hillmen P, Bartlett NL, Li J, Simpson D, Grosicki S, Devereux S, McCarthy H, Coutre S, Quach H, Gaidano G, Maslyak Z, Stevens DA, Janssens A, Offner F, Mayer J, O'Dwyer M, Hellmann A, Schuh A, Siddiqi T, Polliack A, Tam CS, Suri D, Cheng M, Clow F, Styles L, James DF, Kipps TJ; RESONATE-2 Investigators. Burger JA, et al. N Engl J Med. 2015 Dec 17;373(25):2425-37. doi: 10.1056/NEJMoa1509388. Epub 2015 Dec 6. N Engl J Med. 2015. PMID: 26639149 Free PMC article. Clinical Trial.
CLL: ibrutinib and transplantation ride together.
Montserrat E, Delgado J. Montserrat E, et al. Among authors: delgado j. Bone Marrow Transplant. 2016 Jun;51(6):769-70. doi: 10.1038/bmt.2016.118. Epub 2016 May 9. Bone Marrow Transplant. 2016. PMID: 27159178 No abstract available.
Maintenance therapy in chronic lymphocytic leukaemia.
Delgado J, Montserrat E. Delgado J, et al. Lancet Haematol. 2016 Sep;3(9):e399-400. doi: 10.1016/S2352-3026(16)30081-3. Epub 2016 Aug 1. Lancet Haematol. 2016. PMID: 27570083 No abstract available.
Present and future of personalized medicine in CLL.
Montserrat E, Bauman T, Delgado J. Montserrat E, et al. Among authors: delgado j. Best Pract Res Clin Haematol. 2016 Mar;29(1):100-110. doi: 10.1016/j.beha.2016.08.009. Epub 2016 Aug 12. Best Pract Res Clin Haematol. 2016. PMID: 27742064 Review.
2,117 results